Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense Campaign

被引:38
作者
Reich, M. [1 ]
Leemans, C. R. [2 ]
Vermorken, J. B. [3 ]
Bernier, J. [4 ]
Licitra, L. [5 ]
Parmar, S. [6 ]
Golusinski, W. [7 ]
Lefebvre, J. L. [8 ]
机构
[1] Ctr Oscar Lambret, Psychooncol Team, F-59020 Lille, France
[2] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
[3] Univ Antwerp Hosp, Dept Med Oncol, Antwerp, Belgium
[4] Clin Genolier, Dept Radiooncol, Genolier, Switzerland
[5] Ist Nazl Studio & Cura Tumori, I-20133 Milan, Italy
[6] Queen Elizabeth Hosp, Maxillofacial Dept, Birmingham B15 2TH, W Midlands, England
[7] Poznan Univ Med Sci, Greater Poland Canc Ctr, Poznan, Poland
[8] Ctr Oscar Lambret, Dept Head & Neck Canc, F-59020 Lille, France
关键词
SCCHN; emotional support; psycho-oncology; HPV-RELATED HEAD; PSYCHOLOGICAL DISTRESS; HUMAN-PAPILLOMAVIRUS; DEPRESSION; CARE; COMMUNICATION; RECURRENCE; FEAR; SATISFACTION; CARCINOMA;
D O I
10.1093/annonc/mdu105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article reviews the key points for delivering emotional support to squamous cell carcinoma of the head and neck (SCCHN) patients at each stage of their care providing recommendations for better emotional support during the patient journey. It represents an important milestone in the Make Sense Campaign in raising the profile of emotional support within SCCHN as a health priority.Squamous cell carcinoma of the head and neck (SCCHN) is considered a worldwide health care problem. The majority of patients have a history of alcohol abuse and high-level tobacco consumption; however, SCCHN is also associated with exposure to viruses including human papillomavirus (HPV) and Epstein-Barr virus. A major problem facing SCCHN patients is that their disease is often diagnosed at an advanced stage where treatment options may not be curative, or can have severe post-treatment consequences. Confronted with their diagnosis and treatment options, the patient can express a range of emotional reactions which may lead to maladaptive coping. During the SCCHN patient journey, there are a number of stages where emotional support could be offered. A point of contact should be allocated to help patients navigate these stages and deliver practical emotive support (such as encouraging attendance at hospital appointments, compliance with lifestyle modifications and treatment adherence), and to identify if or when more advanced emotive support, in the form of a mental health professional, might be needed. This role might be carried out by a representative within the multidisciplinary health care team (e.g. a nurse). While optimal care is provided by specialist health care professionals, each with specific roles and responsibilities during the patient journey, all are important in screening for emotional distress and providing referral to the mental health team. This article reviews the key points for delivering emotional support to SCCHN patients at each stage of their care. Emotional problems cannot be ignored in SCCHN patients if optimal outcomes are to be achieved, particularly as therapeutic options extend overall survival for many patients. Health care professionals must be able to implement efficient screening for psychological distress to support patient's compliance to their care and treatment. They must also be able to recognize when to refer patients at risk for pharmacological and/or psychotherapeutic interventions.
引用
收藏
页码:2115 / 2124
页数:10
相关论文
共 50 条
[1]   Early self-care rehabilitation of head and neck cancer patients [J].
Ahlberg, Alexander ;
Engstrom, Therese ;
Nikolaidis, Polymnia ;
Gunnarsson, Karin ;
Johansson, Hemming ;
Sharp, Lena ;
Laurell, Goran .
ACTA OTO-LARYNGOLOGICA, 2011, 131 (05) :552-561
[2]   Human Papillomavirus as a Marker of the Natural History and Response to Therapy of Head and Neck Squamous Cell Carcinoma [J].
Ang, Kie Kian ;
Sturgis, Erich M. .
SEMINARS IN RADIATION ONCOLOGY, 2012, 22 (02) :128-142
[3]   Mood and malignancy: head and neck cancer and depression [J].
Archer, Jo ;
Hutchison, Iain ;
Korszun, Ania .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2008, 37 (05) :255-270
[4]  
Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302
[5]   Sharing a diagnosis of HPV-related head and neck cancer: The emotions, the confusion, and what patients want to know [J].
Baxi, Shrujal S. ;
Shuman, Andrew G. ;
Corner, Geoffrey W. ;
Shuk, Elyse ;
Sherman, Eric J. ;
Elkin, Elena B. ;
Hay, Jennifer L. ;
Pfister, David G. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (11) :1534-1541
[6]   Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival [J].
Bonner, James A. ;
Harari, Paul M. ;
Giralt, Jordi ;
Cohen, Roger B. ;
Jones, Christopher U. ;
Sur, Ranjan K. ;
Raben, David ;
Baselga, Jose ;
Spencer, Sharon A. ;
Zhu, Junming ;
Youssoufian, Hagop ;
Rowinsky, Eric K. ;
Ang, K. Kian .
LANCET ONCOLOGY, 2010, 11 (01) :21-28
[7]  
Brédart A, 2005, CURR OPIN ONCOL, V17, P351
[8]  
Buckman R., 1992, BREAK BAD NEWS GUIDE
[9]   PROSPECTIVE STUDY OF PSYCHOSOCIAL DISTRESS AMONG PATIENTS UNDERGOING RADIOTHERAPY FOR HEAD AND NECK CANCER [J].
Chen, Allen M. ;
Jennelle, Richard L. S. ;
Grady, Victoria ;
Tovar, Adrienne ;
Bowen, Kris ;
Simonin, Patty ;
Tracy, Janice ;
McCrudden, Dale ;
Stella, Jonathan R. ;
Vijayakumar, Srinivasan .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (01) :187-193
[10]   Unmet information needs and preferences in newly diagnosed and surgically treated oral cavity cancer patients [J].
Chen, Shu-Ching ;
Lai, Yeur-Hur ;
Liao, Chun-Ta ;
Chang, Joseph Tung-Chien ;
Lin, Chia-Chin .
ORAL ONCOLOGY, 2009, 45 (11) :946-952